Table 1 Baseline demographics, mesothelins and survival
From: A prospective study to investigate the role of serial serum mesothelin in monitoring mesothelioma
Post-chemotherapy | Non-chemotherapy | |
|---|---|---|
Number | 23 | 18 |
Median age (range) | 69 (58–77) | 75 (67–83) |
Male/Female | 22/1 | 13/5 |
Histology | ||
Epithelioid | 14 | 11 |
Biphasic | 3 | 1 |
Sarcomatoid | 5 | 4 |
Unknown | 1 | 2 |
Baseline mesothelin | ||
Median | 1.9 | 3.4 |
(IQR) | (1.2–13.4) | (1.2–6.4) |
Survival (months) | ||
Median | 17 | 10 |
(IQR) | (14–26) | (7–22) |